VR ADVISER, LLC
· CIK 0001615982| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | VOR | VOR BIOPHARMA INC | Healthcare | 499,966.0 | $24.4M | 1.37% | NEW | — | $48.72 | -70.0% |
| 22 | — | UPSTREAM BIO INC | — | 1,169,298.0 | $22.0M | 1.24% | NEW | — | $18.81 | — |
| 23 | — | ZURA BIO LTD | — | 4,631,216.0 | $20.1M | 1.13% | NEW | — | $4.33 | — |
| 24 | — | ASTRIA THERAPEUTICS INC | — | 2,457,348.0 | $17.9M | 1.01% | NEW | — | $7.28 | — |
| 25 | PHVS | PHARVARIS N V | Healthcare | 674,599.0 | $16.8M | 0.95% | NEW | — | $24.95 | +23.0% |
| 26 | — | CRESCENT BIOPHARMA INC. | — | 1,387,864.0 | $16.5M | 0.93% | NEW | — | $11.89 | — |
| 27 | SEPN | SEPTERNA INC | Healthcare | 610,808.0 | $11.5M | 0.65% | NEW | — | $18.81 | +50.6% |
| 28 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 1,379,965.0 | $8.2M | 0.46% | NEW | — | $5.93 | +165.3% |
| 29 | — | SURROZEN INC | — | 632,931.0 | $8.2M | 0.46% | NEW | — | $12.89 | — |
| 30 | — | PERCEPTIVE CAP SOLUTIONS COR | — | 750,000.0 | $8.0M | 0.45% | NEW | — | $10.60 | — |
| 31 | — | ARTIVA BIOTHERAPEUTICS INC | — | 1,609,569.0 | $4.6M | 0.26% | NEW | — | $2.87 | — |
| 32 | — | TENAX THERAPEUTICS INC | — | 437,708.0 | $3.3M | 0.19% | NEW | — | $7.61 | — |
| 33 | — | CASI PHARMACEUTICALS INC | — | 987,259.0 | $1.6M | 0.09% | NEW | — | $1.66 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%